Publications by authors named "Constantin Kuna"

Claim this Profile
D
Diabetes-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis.
Constantin Kuna, Eduard Braun, Christian Bradaric, Tobias Koch, Antonia Presch

Clin Res Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-Eluting Stent Implantation or Drug-Coated Balloon Angioplasty According to Neointima Morphology in Drug-Eluting Stent REstenosis 5: Rationale and Design of the ISAR-DESIRE 5 Trial.
Fiorenzo Simonetti, Felix Voll, Fernando Alfonso, Christian Gräßer, Marion Janisch, Constantin Kuna

J Cardiovasc Transl Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year clinical outcomes after left main coronary artery stenting with new-generation or early-generation DES.
Jens Wiebe, Constantin Kuna, Tareq Ibrahim, Sebastian Kufner, Isabella Hintz

Rev Esp Cardiol (Engl Ed)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis.
Constantin Kuna, Christian Bradaric, Tobias Koch, Antonia Presch, Felix Voll

Int J Cardiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-related outcomes after percutaneous coronary intervention of in-stent restenosis.
Constantin Kuna, Christian Bradaric, Mira Schroeter, Antonia Presch, Felix Voll

Cardiovasc Interv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis.
Felix Voll, Constantin Kuna, Maria Scalamogna, Thorsten Kessler, Sebastian Kufner

Rev Esp Cardiol (Engl Ed)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary Stenting.
Jens Wiebe, Robert A Byrne, Christian Bradaric, Constantin Kuna, Thorsten Kessler

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials.
Maria Scalamogna, Constantin Kuna, Felix Voll, Alp Aytekin, Shqipdona Lahu

Clin Res Cardiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
Constantin Kuna, Nadine Wiedenmayer, Christian Bradaric, Antonia Presch, Felix Voll

Catheter Cardiovasc Interv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of long-term outcome in patients with calcified stenosis treated with intravascular lithotripsy or with modified balloon angioplasty: a propensity score-adjusted study.
Jürgen Leick, Tobias Rheude, Michael Denne, Salvatore Cassese, Adnan Kastrati, Constantin Kuna

Front Cardiovasc Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
J J Coughlan, Alp Aytekin, Shqipdona Lahu, Maria Scalamogna, Jens Wiebe, Constantin Kuna

EuroIntervention· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial.
Tobias Heer, Moritz von Scheidt, Andreas Boening, Clarissa Heyken, Friederike Gusmini, Constantin Kuna

Eur J Cardiothorac Surg· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy With or Without Aspirin After Percutaneous Coronary Intervention or Acute Coronary Syndrome in Patients Taking Oral Anticoagulation: A Meta-Analysis and Network Analysis of Randomized Controlled Trials.
Róisín Colleran, Robert A Byrne, Gjin Ndrepepa, Hector A Alvarez-Covarrubias, Katharina Mayer, Constantin Kuna

Cardiovasc Revasc Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial.
Jens Wiebe, Robert A Byrne, Fernando Alfonso, Michael Maeng, Christian Bradaric, Constantin Kuna

EuroIntervention· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
Jens Wiebe, Himanshu Rai, Constantin Kuna, Salvatore Cassese, Thorsten Kessler

Catheter Cardiovasc Interv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice.
Jens Wiebe, Petra Hoppmann, Salvatore Cassese, Tobias Rheude, Roisin Colleran, Constantin Kuna

Rev Esp Cardiol (Engl Ed)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic treatment in primary percutaneous coronary intervention.
Felix Voll, Constantin Kuna, Gjin Ndrepepa, Adnan Kastrati, Salvatore Cassese

Expert Rev Cardiovasc Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta-Analysis.
Jens Wiebe, Gjin Ndrepepa, Sebastian Kufner, Anna L Lahmann, Erion Xhepa, Constantin Kuna

J Am Heart Assoc· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization.
Jens Wiebe, Constantin Kuna, Tareq Ibrahim, Martin Lösl, Salvatore Cassese

JACC Cardiovasc Interv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?
Yukinori Harada, Simon Schneider, Roisin Colleran, Himanshu Rai, Janika Bohner, Constantin Kuna

Rev Esp Cardiol (Engl Ed)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
Heribert Schunkert, Andreas Boening, Moritz von Scheidt, Clarissa Lanig, Friederike Gusmini, Constantin Kuna

Eur Heart J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
Thomas Schmidt, Henrik Nienhüser, Constantin Kuna, Johannes Klose, Moritz J Strowitzki

Eur J Surg Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis